Tag: Acerus Pharmaceuticals

July 19, 2019

Acerus Announces Closing of US$5 Million Secured Term Loan

Acerus Pharmaceuticals (TSX:ASP, OTCQB:ASPCF) has announced it has entered into a US$5 million subordinated secured term loan facility with First...
June 6, 2019

VIDEO — US vs. Canada Healthcare Systems: Is One Better?

INN asked four company CEOs their thoughts on the US and Canadian healthcare systems and whether one is better than...
May 16, 2019

VIDEO Round-Up BBHIC 2019

BBHIC is over for another year. In case you missed it, here's a compilation of all INN's video interviews from...
May 10, 2019

VIDEO — Acerus Pharma CEO: Keeping Focus on Drug Delivery Tech, Not Cannabis

In this BBHIC interview, Acerus Pharmaceuticals CEO Ed Gudaitis explains why the company isn't directly pursuing the cannabis market.
May 1, 2019

BBHIC 2019, Day 2: Notes From the Floor

The second day of the show had more company presentations, interviews and a panel discussion on R&D-stage healthcare companies.
March 5, 2019

Shares of Acerus Pharma Dip Amid Q4 and 2018 Financial Results

Shares of Acerus Pharmaceuticals dipped 7.14 percent on Tuesday following the release of its Q4 and fiscal 2018 financial results.
January 25, 2019

Acerus Receives Notice of Deficiency – Withdrawal Letter from Health Canada Regarding Gynoflor Application

Acerus Pharmaceuticals (TSX:ASP) is today advising that it has received a Notice of Deficiency-Withdrawal Letter for its Gynoflor New Drug Submission....